Effects of obesity surgery on the metabolic syndrome

Archives of Surgery

Volumn 139, Issue 10, 2004, Pages 1088-1092

  Lee, Wei Jei ^a,b   Huang, Ming Te ^a,b   Wang, Weu ^a,b   Lin, Ching Mei ^a,b   Chen, Tai Chi ^a,b   Lai, I Ru ^a,b  

^a EN CHU KONG HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; FEMALE; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LAPAROSCOPIC SURGERY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SEX DIFFERENCE; STOMACH BYPASS; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES;

EID: 5444247120     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.10.1088     Document Type: Article

References (37)

1. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41:715-722.
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
3. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study. Am J Epidemiol. 1998;148:958-966.
4. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
5. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care. 2001;24:1936-1940.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NECP) Expert Panel of Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
7. Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab. 2002;4:407-414.
8. NIH conference: gastrointestinal surgery for severe obesity. Ann Int Med. 1991;115:959-961.
9. Lee WJ, Lai IR, Huang MT, Wu CC, Wei PL. Laparoscopic versus open vertical banded gastroplasty for the treatment of morbid obesity. Surg Laparosc Endosc Percutan Tech. 2001;11:9-13.
10. Higa K, Boone K, Ho T, Davies O. Laparoscopic Roux-en-Y gastric bypass for morbid obesity. Arch Surg. 2000;135:1029-1034.
11. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The continuing epidemic of obesity in the United States. JAMA. 2000;284:1650-1651.
12. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med. 1999;245:163-174.
13. Hulthe J, Bokemark L, Wikstrand J, Fagerberg B. The metabolic syndrome, LDL particle size and atherosclerosis and insulin resistance (AIR) study. Arterioscler Thromb Vasc Biol. 2000;20:2140-2147.
14. Adami SF, Ravera G, Marinari GM, Camerini G, Scopinaro N. Metabolic syndrome in severely obese patients. Obes Surg. 2001;11:543-545.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;287:356-359.
16. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999;83:25F-29F.
17. Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001;109(suppl 2):S135-S148.
18. Maison P, Byrne CD, Hales CN, Day NE, Wareham NJ. Do different dimensions of the metabolic syndrome change together over time? evidence supporting obesity as the central feature. Diabetes Care. 2001;24:1758-1763.
19. Livingston EH, Huerta S, Arthur D, Lee S, De Shields S, Heber D. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg. 2002;236:576-582.
20. Wittgrove A, Clark G. Laparoscopic gastric bypass, Roux-en-Y: 500 patients, technique and results, with 3-60 month follow-up. Obes Surg. 2000;10:233-239.
21. Schauer P, Ikranuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic gastric bypass for morbid obesity. Ann Surg. 2000;232:515-529.
22. Nguyen N, Goldman C, Rosenquist J, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg. 2001;234:279-291.
23. DeMaria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LS. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235:640-647.
24. Eriksson KF, Lindgrade F. Prevention of type 2 (non-insulin-independent) diabetes mellitus by diet and physical exercise: the 6-year Malmo feasibility study. Diabetologia. 1991;34:891-898.
25. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
26. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in life-style among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
27. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? an operation proved to be the most effective therapy of adult-onset of diabetes mellitus. Ann Surg. 1995;222:339-352.
28. Yashkov YI, Timoshin AD, Oppel TA. Vertical banded gastroplasty: first experience in Russia. Obes Surg. 1997;7:317-320.
29. O'Brien PE, Brown WA, Smith PJ, McMurrick PJ, Stephens M. Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity. Br J Surg. 1999;86:113-118.
30. Carson JL, Ruddy ME, Duff AE, Holmes NJ, Cody RP, Brolin RE. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med. 1994;154:193-200.
31. Sjostorm CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS interventional study. Obes Res. 1999;7:477-484.
32. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131-2135.
33. Nakanishi N, Sato M, Shirai K, et al. Association between white blood cell count and features of the metabolic syndrome in Japanese male office workers. Ind Health. 2002;40:273-277.
34. Chambers JC, Eda S, Bassett P, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 2001;104:145-150.
35. Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord. 2002;26:659-662.
36. Cottam DR, Schaefer PA, Shaftan GW, Velcu L, Angus LD. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg. 2002;12:335-342.
37. Lee WJ, Yu PJ, Wang W, Lin CM, Wei PL, Huang MT. Gastrointestinal quality of life following laparoscopic vertical banded gastroplasty. Obes Surg. 2002;12:819-824.